Caricamento...
Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells
SARS-CoV-2, which causes COVID-19 disease, is one of greatest global pandemics in history. No effective treatment is currently available for severe COVID-19 disease. One strategy for implementing cell-based immunity involves the use of chimeric antigen receptor (CAR) technology. Unlike CAR T cells,...
Salvato in:
| Pubblicato in: | bioRxiv |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Cold Spring Harbor Laboratory
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430572/ https://ncbi.nlm.nih.gov/pubmed/32817942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.11.247320 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|